With the NHS increasingly under pressure to deliver more with less, services must consider how they can innovate in order to make the most efficient use of existing resources. This means seeing the right patient, in the right place, at the right time with the shortest-possible waiting time, especially for those patients waiting for a cancer diagnosis.
Astrazeneca | Deloitte UK
Merlin is a truly innovative, truly collaborative and truly transformative flagship first in science project both for AstraZeneca and the industry as a whole. It redefines how clinical trial studies are designed, putting the patient at the centre. In turning an exceptional idea into a concrete vision and reality AstraZeneca enlisted the help of Deloitte. Find out more.
Merck, Sharpe and Dohme - Insights for Care
GM wanted to tackle the health inequalities and inconsistency in care, and asked Deloitte to support it on important commissioned work, to go on an unchartered journey to radically transform the provision of health and social care services.